• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Interpretation of diagnosis of multiple myeloma in the guidelines for the diagnosis and management of multiple myeloma in China (2022 revision)].

作者信息

Du J, Hou Jian

机构信息

Department of Hematology, Shanghai Changzheng Hospital, Shanghai 200003,China.

Department of Hematology,Shanghai Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200120, China.

出版信息

Zhonghua Nei Ke Za Zhi. 2022 May 1;61(5):463-465. doi: 10.3760/cma.j.cn112138-20220316-00182.

DOI:10.3760/cma.j.cn112138-20220316-00182
PMID:35488593
Abstract
摘要

相似文献

1
[Interpretation of diagnosis of multiple myeloma in the guidelines for the diagnosis and management of multiple myeloma in China (2022 revision)].[中国多发性骨髓瘤诊断与治疗指南（2022年修订版）中多发性骨髓瘤诊断的解读]
Zhonghua Nei Ke Za Zhi. 2022 May 1;61(5):463-465. doi: 10.3760/cma.j.cn112138-20220316-00182.
2
[The guidelines for the diagnosis and management of multiple myeloma in China (2015 revision) : interpretation of the treatment of relapsing and refractory multiple myeloma].中国多发性骨髓瘤诊断与治疗指南（2015年修订版）：复发/难治性多发性骨髓瘤治疗解读
Zhonghua Nei Ke Za Zhi. 2016 Feb;55(2):93-4. doi: 10.3760/cma.j.issn.0578-1426.2016.02.004.
3
[The guidelines for the diagnosis and management of multiple myeloma in China (2015 revision) : interpretation of diagnosis].《中国多发性骨髓瘤诊治指南（2015年修订版）：诊断解读》
Zhonghua Nei Ke Za Zhi. 2016 Feb;55(2):91-2. doi: 10.3760/cma.j.issn.0578-1426.2016.02.002.
4
[The guidelines for the diagnosis and management of multiple myeloma in China (2015 revision) : interpretation of initial treatment].《中国多发性骨髓瘤诊治指南（2015年修订版）：初始治疗解读》
Zhonghua Nei Ke Za Zhi. 2016 Feb;55(2):92-3. doi: 10.3760/cma.j.issn.0578-1426.2016.02.003.
5
[The guidelines for the diagnosis and management of multiple myeloma in China (2015 revision) : interpretation of response criteria].《中国多发性骨髓瘤诊治指南（2015年修订版）：疗效标准解读》
Zhonghua Nei Ke Za Zhi. 2016 Feb;55(2):94-6. doi: 10.3760/cma.j.issn.0578-1426.2016.02.005.
6
[Interpretation of treatment of relapsed/refractory multiple myeloma patients in the guidelines for the diagnosis and management of multiple myeloma in China(2022 revision)].[《中国多发性骨髓瘤诊断与治疗指南（2022年修订版）》中复发/难治性多发性骨髓瘤患者的治疗解读]
Zhonghua Nei Ke Za Zhi. 2022 May 1;61(5):469-473. doi: 10.3760/cma.j.cn112138-20220414-00278.
7
[Interpretation of treatment for newly diagnosed multiple myeloma patients in the guidelines for the diagnosis and management of multiple myeloma in China (2022 revision)].
Zhonghua Nei Ke Za Zhi. 2022 May 1;61(5):465-469. doi: 10.3760/cma.j.cn112138-20220309-00162.
8
[Interpretation of minimal residual disease monitoring for response evaluation in "the guidelines for the diagnosis and management of multiple myeloma in China(2020 revision)"].《解读<中国多发性骨髓瘤诊断与治疗指南（2020年修订版）>中微小残留病监测用于疗效评估》
Zhonghua Nei Ke Za Zhi. 2020 May 1;59(5):332-334. doi: 10.3760/cma.j.cn112138-20200217-00084.
9
[Best wishes to the guidelines for the diagnosis and management of multiple myeloma in China (2020 revision)].[祝《中国多发性骨髓瘤诊断与治疗指南（2020年修订版）》顺利]
Zhonghua Nei Ke Za Zhi. 2020 May 1;59(5):329-331. doi: 10.3760/cma.j.cn112138-20200309-00208.
10
[The guidelines for the diagnosis and management of multiple myeloma in China (2017 revision)].中国多发性骨髓瘤诊断与治疗指南（2017年修订版）
Zhonghua Nei Ke Za Zhi. 2017 Nov 1;56(11):866-870. doi: 10.3760/cma.j.issn.0578-1426.2017.11.021.